The incidence of glioblastoma, previously described as a disease predominantly affecting non‐Hispanic White patients, was higher among non‐White patients in the authors' recent study in which the racial/ethnical composition of the patients was representative of the overall population. These findings offer an opportunity to accurately redefine the patient population of patients with glioblastoma bearing the burden of this disease in the United States.
No takes yet. Share an insight, caveat, or question.
Asfaw et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: